Airway Therapeutics Appoints Biopharma Leader Joe Todisco to Board of Directors
Appointment brings deep commercial and corporate development expertise to support advancement of zelpultide alfa and future growth MARIETTA, Ga., April 13, 2026 /PRNewswire/ — Airway Therapeutics, Inc., a late-stage clinical biopharmaceutical company
